Oct 4, 2026
FDA advances first government-funded ibogaine clinical trials for opioid addiction and PTSD
U.S. health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder. The FDA announced Monday it is seeking public feedback on safety rules for the studies.
6 sources
00